awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41668880-910F48FD-59FF-465D-9A7F-C5E0DEEEDDC2
Q41668880-910F48FD-59FF-465D-9A7F-C5E0DEEEDDC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41668880-910F48FD-59FF-465D-9A7F-C5E0DEEEDDC2
A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab.
P2860
Q41668880-910F48FD-59FF-465D-9A7F-C5E0DEEEDDC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41668880-910F48FD-59FF-465D-9A7F-C5E0DEEEDDC2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
89062d715eacc16740f917a4cde3e082fe3ce4b6
P2860
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.